Subscribe
About us
Advertise with us

NeuroSens

Menu

Skip to content

Home
Neurology
Psychiatry

Topic: LGS

Clobazam in Lennox-Gastaut syndrome: phase III results

August 29, 2012

Browse by Topic

MS (311)
AD (81)
PD (77)
COVID-19 (46)
PREVIOUS CONGRESSES (37)
DEPRESSION (36)
MIGRAINE (26)

SCHIZOPHRENIA (25)
STROKE (22)
EPILEPSY (21)
ECTRIMS 2015 (13)
AAN 2015 (11)
ECTRIMS 2021 (10)
DEMENTIA (10)
ECTRIMS 2014 (10)
ECTRIMS 2019 (10)
AAN 2013 (9)
ECTRIMS 2013 (9)
ECTRIMS 2018 (9)
AAN 2014 (9)
MS SEQUENCING (9)
PSYCHIATRY (8)
AAN 2019 (7)
ACTRIMS-ECTRIMS 2020 (7)
ECTRIMS 2017 (6)
CHARCOT 2013 (6)
AAN 2021 (6)
Library (6)
ECTRIMS 2016 (5)
BIPOLAR (5)
CCSVI (5)
AAN 2022 (5)
ANXIETY (5)
NeuroSound (4)
BPD (4)
EAN 2015 (4)
AAN 2020 (3)
AAN 2017 (3)
ENS 2013 (3)
EAN 2022 (3)
PAIN (3)
EAN 2020 (2)
SLEEP (2)
NEW DRUGS (2)
AAN 2018 (2)
APA 2014 (2)
SPECIAL REPORT (2)
EAN 2021 (1)
ACTRIMS 2022 (1)
WEST NILE (1)
GUIDELINES (1)
LUMBAR PUNCTURE (1)
INSOMNIA (1)
AAN 2016 (1)
TSC (1)
EAN 2019 (1)
APA 2016 (1)
SEIZURE (1)
hATTR (1)
Dravet syndrome (1)
CIDP (1)
CONCUSSION (1)
ALS (1)
LGS (1)
ADDICTION (1)
ECTRIMS 2020 (0)
CLINICAL CASES IN MS (0)
EAN 2016 (0)

View all Topics

Popular Posts

Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
Progression independent of relapses (PIRA) in MS posted on November 21, 2019
CLINICAL CASES IN MS – CASE 5: A CLINICALLY STABLE PATIENT PLANNING A PREGNANCY posted on June 15, 2022

Copyright 2022 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)

Contact Us Terms and Conditions